Rank | Gene Set | Z-score |
---|---|---|
1 | sarcomere organization (GO:0045214) | 9.50799062 |
2 | cardiac myofibril assembly (GO:0055003) | 9.02739203 |
3 | * actin-myosin filament sliding (GO:0033275) | 8.28488585 |
4 | * muscle filament sliding (GO:0030049) | 8.28488585 |
5 | myofibril assembly (GO:0030239) | 8.27052174 |
6 | cardiac muscle contraction (GO:0060048) | 7.07853340 |
7 | * actin-mediated cell contraction (GO:0070252) | 6.83500913 |
8 | plasma membrane repair (GO:0001778) | 6.69085127 |
9 | cardiac muscle cell development (GO:0055013) | 6.64594541 |
10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.63229462 |
11 | * negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.53446657 |
12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.52091878 |
13 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.48848227 |
14 | regulation of skeletal muscle contraction (GO:0014819) | 6.44323234 |
15 | cardiac cell development (GO:0055006) | 6.24264745 |
16 | tricarboxylic acid cycle (GO:0006099) | 6.19217944 |
17 | actomyosin structure organization (GO:0031032) | 6.18497110 |
18 | * negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.07631926 |
19 | regulation of actin filament-based movement (GO:1903115) | 6.05643309 |
20 | regulation of relaxation of muscle (GO:1901077) | 6.04815206 |
21 | cardiac muscle tissue morphogenesis (GO:0055008) | 6.03191314 |
22 | adult heart development (GO:0007512) | 6.02440292 |
23 | striated muscle contraction (GO:0006941) | 5.95248305 |
24 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.93844502 |
25 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.83227206 |
26 | cardiac muscle hypertrophy (GO:0003300) | 5.78344527 |
27 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.78014629 |
28 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.73497444 |
29 | regulation of sarcomere organization (GO:0060297) | 5.67925113 |
30 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.55827638 |
31 | striated muscle hypertrophy (GO:0014897) | 5.50976312 |
32 | muscle tissue morphogenesis (GO:0060415) | 5.43358331 |
33 | heart trabecula formation (GO:0060347) | 5.28447651 |
34 | heart process (GO:0003015) | 5.27772173 |
35 | heart contraction (GO:0060047) | 5.27772173 |
36 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.27391300 |
37 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.19028904 |
38 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.14580306 |
39 | regulation of striated muscle contraction (GO:0006942) | 5.12900995 |
40 | * actin filament-based movement (GO:0030048) | 5.09970104 |
41 | regulation of cell communication by electrical coupling (GO:0010649) | 5.08557343 |
42 | carnitine shuttle (GO:0006853) | 5.00902188 |
43 | regulation of membrane repolarization (GO:0060306) | 4.99614828 |
44 | regulation of the force of heart contraction (GO:0002026) | 4.90684846 |
45 | muscle hypertrophy (GO:0014896) | 4.88273058 |
46 | skeletal muscle adaptation (GO:0043501) | 4.87768045 |
47 | response to muscle activity (GO:0014850) | 4.85784820 |
48 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.82358514 |
49 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.73250574 |
50 | cell communication involved in cardiac conduction (GO:0086065) | 4.63513798 |
51 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.48125292 |
52 | striated muscle atrophy (GO:0014891) | 4.40606421 |
53 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.38934853 |
54 | regulation of cofactor metabolic process (GO:0051193) | 4.32963476 |
55 | regulation of coenzyme metabolic process (GO:0051196) | 4.32963476 |
56 | skeletal muscle contraction (GO:0003009) | 4.32385132 |
57 | fatty acid transmembrane transport (GO:1902001) | 4.26173390 |
58 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.25287100 |
59 | muscle hypertrophy in response to stress (GO:0003299) | 4.25287100 |
60 | cardiac muscle adaptation (GO:0014887) | 4.25287100 |
61 | muscle fiber development (GO:0048747) | 4.24799530 |
62 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.23317082 |
63 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.21579526 |
64 | cardiac muscle cell action potential (GO:0086001) | 4.19025100 |
65 | cell communication by electrical coupling (GO:0010644) | 4.16528791 |
66 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.16123997 |
67 | regulation of cardiac muscle contraction (GO:0055117) | 4.11406428 |
68 | regulation of heart rate (GO:0002027) | 4.11365143 |
69 | regulation of cardioblast differentiation (GO:0051890) | 4.08082266 |
70 | striated muscle cell development (GO:0055002) | 3.99463757 |
71 | muscle atrophy (GO:0014889) | 3.93972377 |
72 | regulation of ATP catabolic process (GO:1903289) | 3.93945071 |
73 | regulation of ATPase activity (GO:0043462) | 3.93945071 |
74 | skeletal muscle fiber development (GO:0048741) | 3.93188809 |
75 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.92846719 |
76 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.91778863 |
77 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.90334517 |
78 | ATP synthesis coupled proton transport (GO:0015986) | 3.90334517 |
79 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.87357733 |
80 | * muscle contraction (GO:0006936) | 3.84045620 |
81 | ventricular cardiac muscle cell development (GO:0055015) | 3.81260823 |
82 | regulation of heart contraction (GO:0008016) | 3.78092448 |
83 | oxidative phosphorylation (GO:0006119) | 3.74445253 |
84 | regulation of muscle system process (GO:0090257) | 3.73547561 |
85 | myotube cell development (GO:0014904) | 3.73426014 |
86 | relaxation of cardiac muscle (GO:0055119) | 3.72378540 |
87 | NADH metabolic process (GO:0006734) | 3.70404172 |
88 | cardiac conduction (GO:0061337) | 3.68025731 |
89 | muscle adaptation (GO:0043500) | 3.67288424 |
90 | response to inactivity (GO:0014854) | 3.66021745 |
91 | carnitine transmembrane transport (GO:1902603) | 3.65400196 |
92 | detection of calcium ion (GO:0005513) | 3.65283320 |
93 | respiratory electron transport chain (GO:0022904) | 3.64613298 |
94 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.64532446 |
95 | striated muscle adaptation (GO:0014888) | 3.63382202 |
96 | response to epinephrine (GO:0071871) | 3.61577043 |
97 | cellular response to epinephrine stimulus (GO:0071872) | 3.60675861 |
98 | skeletal muscle tissue development (GO:0007519) | 3.59533656 |
99 | * muscle system process (GO:0003012) | 3.59234543 |
100 | cardiac chamber formation (GO:0003207) | 3.59206563 |
101 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.57410184 |
102 | creatine metabolic process (GO:0006600) | 3.56533369 |
103 | response to caffeine (GO:0031000) | 3.55665638 |
104 | muscle cell cellular homeostasis (GO:0046716) | 3.53681960 |
105 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.53665651 |
106 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.53665651 |
107 | electron transport chain (GO:0022900) | 3.53433715 |
108 | regulation of muscle contraction (GO:0006937) | 3.52521446 |
109 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.51945681 |
110 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.51945681 |
111 | regulation of sulfur metabolic process (GO:0042762) | 3.50555332 |
112 | 2-oxoglutarate metabolic process (GO:0006103) | 3.44472157 |
113 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.44282783 |
114 | muscle cell development (GO:0055001) | 3.42730060 |
115 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.42286751 |
116 | trabecula formation (GO:0060343) | 3.41488847 |
117 | positive regulation of cation channel activity (GO:2001259) | 3.40039277 |
118 | positive regulation of myotube differentiation (GO:0010831) | 3.39357278 |
119 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.35001938 |
120 | cardiac ventricle formation (GO:0003211) | 3.30948026 |
121 | carnitine transport (GO:0015879) | 3.30468328 |
122 | amino-acid betaine transport (GO:0015838) | 3.30468328 |
123 | relaxation of muscle (GO:0090075) | 3.29891913 |
124 | muscle cell fate commitment (GO:0042693) | 3.28854915 |
125 | glycogen catabolic process (GO:0005980) | 3.27471816 |
126 | muscle organ development (GO:0007517) | 3.23116686 |
127 | muscle structure development (GO:0061061) | 3.20986972 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.11585659 |
2 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.10073396 |
3 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.46795281 |
4 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.20073287 |
5 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.20073287 |
6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.49984521 |
7 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.48429074 |
8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.42627376 |
9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.99100687 |
10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.96934364 |
11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.92517475 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.80561573 |
13 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.53715606 |
14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.52960001 |
15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.48466140 |
16 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.37127408 |
17 | * RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.12870391 |
18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.10271842 |
19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.97108244 |
20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.91647535 |
21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.90639213 |
22 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.85300741 |
23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.83909015 |
24 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.71119259 |
25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.66510459 |
26 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.60936353 |
27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.52904253 |
28 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.46348127 |
29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.42290736 |
30 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.41758159 |
31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40418955 |
32 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.38566008 |
33 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.35898070 |
34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.34845442 |
35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33650913 |
36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.31756268 |
37 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.31570759 |
38 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.29679931 |
39 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.27470062 |
40 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.24831398 |
41 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.24242814 |
42 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.17017025 |
43 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.15844178 |
44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.15580640 |
45 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.14890107 |
46 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.14656532 |
47 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.13280404 |
48 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.12483328 |
49 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.11786603 |
50 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.11532560 |
51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11107574 |
52 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11001472 |
53 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09088550 |
54 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.08751677 |
55 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08063140 |
56 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07935277 |
57 | VDR_22108803_ChIP-Seq_LS180_Human | 1.06784630 |
58 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06142084 |
59 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.06062523 |
60 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.05394791 |
61 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04871255 |
62 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03686967 |
63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.03069095 |
64 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02266378 |
65 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00719069 |
66 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00508923 |
67 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99568123 |
68 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.99402702 |
69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97956837 |
70 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.97363427 |
71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97055364 |
72 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96379062 |
73 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.96288912 |
74 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95066980 |
75 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.93955992 |
76 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93328035 |
77 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.93237697 |
78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93135409 |
79 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.92796008 |
80 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.92692344 |
81 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92606051 |
82 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.92482500 |
83 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.92410753 |
84 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91793786 |
85 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91683485 |
86 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.90798568 |
87 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.90673540 |
88 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.90673540 |
89 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.90422844 |
90 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.89911545 |
91 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.89591341 |
92 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.88399787 |
93 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.88365898 |
94 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87950924 |
95 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87296121 |
96 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86959759 |
97 | P68_20966046_ChIP-Seq_HELA_Human | 0.86655026 |
98 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.86564264 |
99 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.85637041 |
100 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85289468 |
101 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85289468 |
102 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.85007517 |
103 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84366515 |
104 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84006849 |
105 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.83829781 |
106 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.83779118 |
107 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.82547020 |
108 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.82522214 |
109 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.82337613 |
110 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.82236363 |
111 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.81907779 |
112 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81771902 |
113 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.81732714 |
114 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.81699652 |
115 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.81156746 |
116 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.80932079 |
117 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.80798579 |
118 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80700288 |
119 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79846157 |
120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79502422 |
121 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.79212888 |
122 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.78916165 |
123 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.78632068 |
124 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.77962412 |
125 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.76845126 |
126 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.76752680 |
127 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.76653963 |
128 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.76347735 |
129 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76148204 |
130 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.75902466 |
131 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75756841 |
132 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74785096 |
133 | * GF1_26923725_Chip-Seq_HPCs_Mouse | 0.73723302 |
134 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.72245553 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 6.67365604 |
2 | MP0004084_abnormal_cardiac_muscle | 5.92182650 |
3 | MP0003646_muscle_fatigue | 5.42460757 |
4 | MP0000751_myopathy | 5.24841116 |
5 | MP0004215_abnormal_myocardial_fiber | 4.67416402 |
6 | MP0004036_abnormal_muscle_relaxation | 4.50815793 |
7 | MP0000749_muscle_degeneration | 4.31768060 |
8 | MP0005330_cardiomyopathy | 3.95849156 |
9 | MP0002972_abnormal_cardiac_muscle | 3.24362586 |
10 | MP0004087_abnormal_muscle_fiber | 3.23872225 |
11 | MP0003137_abnormal_impulse_conducting | 2.92992219 |
12 | MP0008775_abnormal_heart_ventricle | 2.91398750 |
13 | MP0005620_abnormal_muscle_contractility | 2.89049064 |
14 | MP0004145_abnormal_muscle_electrophysio | 2.79637758 |
15 | MP0000750_abnormal_muscle_regeneration | 2.78977440 |
16 | MP0002106_abnormal_muscle_physiology | 2.73672196 |
17 | MP0010630_abnormal_cardiac_muscle | 2.64624189 |
18 | MP0001544_abnormal_cardiovascular_syste | 2.60843235 |
19 | MP0005385_cardiovascular_system_phenoty | 2.60843235 |
20 | MP0006138_congestive_heart_failure | 2.45101966 |
21 | MP0004484_altered_response_of | 2.40535338 |
22 | MP0002269_muscular_atrophy | 2.39744069 |
23 | MP0004130_abnormal_muscle_cell | 2.34472089 |
24 | MP0003828_pulmonary_edema | 2.30340220 |
25 | MP0000747_muscle_weakness | 2.22736157 |
26 | MP0005369_muscle_phenotype | 2.21580111 |
27 | MP0004085_abnormal_heartbeat | 2.13735564 |
28 | MP0000759_abnormal_skeletal_muscle | 2.13686873 |
29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.96464301 |
30 | MP0004510_myositis | 1.88420309 |
31 | MP0004233_abnormal_muscle_weight | 1.78513237 |
32 | MP0003950_abnormal_plasma_membrane | 1.75669029 |
33 | MP0002127_abnormal_cardiovascular_syste | 1.72300346 |
34 | MP0006036_abnormal_mitochondrial_physio | 1.64314820 |
35 | MP0002332_abnormal_exercise_endurance | 1.41030227 |
36 | MP0003567_abnormal_fetal_cardiomyocyte | 1.38982963 |
37 | MP0005666_abnormal_adipose_tissue | 1.24023283 |
38 | MP0002234_abnormal_pharynx_morphology | 1.20059029 |
39 | MP0000266_abnormal_heart_morphology | 1.16036515 |
40 | MP0003279_aneurysm | 1.06665179 |
41 | MP0000343_altered_response_to | 1.04760841 |
42 | MP0005670_abnormal_white_adipose | 1.04453231 |
43 | MP0010368_abnormal_lymphatic_system | 1.01573949 |
44 | MP0004270_analgesia | 1.00225348 |
45 | MP0006035_abnormal_mitochondrial_morpho | 0.97045054 |
46 | MP0005165_increased_susceptibility_to | 0.91945027 |
47 | MP0002108_abnormal_muscle_morphology | 0.91033719 |
48 | MP0005451_abnormal_body_composition | 0.88889256 |
49 | MP0001661_extended_life_span | 0.86097176 |
50 | MP0004185_abnormal_adipocyte_glucose | 0.84973165 |
51 | MP0005375_adipose_tissue_phenotype | 0.84002747 |
52 | MP0000733_abnormal_muscle_development | 0.83277541 |
53 | MP0002128_abnormal_blood_circulation | 0.77304177 |
54 | MP0003566_abnormal_cell_adhesion | 0.77010674 |
55 | MP0005266_abnormal_metabolism | 0.76450382 |
56 | MP0000230_abnormal_systemic_arterial | 0.74875601 |
57 | MP0005623_abnormal_meninges_morphology | 0.74840613 |
58 | MP0003705_abnormal_hypodermis_morpholog | 0.68786947 |
59 | MP0004272_abnormal_basement_membrane | 0.61860407 |
60 | MP0000767_abnormal_smooth_muscle | 0.61144851 |
61 | MP0002909_abnormal_adrenal_gland | 0.58687146 |
62 | MP0000013_abnormal_adipose_tissue | 0.57728918 |
63 | MP0001879_abnormal_lymphatic_vessel | 0.56811356 |
64 | MP0003045_fibrosis | 0.54927815 |
65 | MP0002971_abnormal_brown_adipose | 0.50315576 |
66 | MP0003806_abnormal_nucleotide_metabolis | 0.49653134 |
67 | MP0005275_abnormal_skin_tensile | 0.49644165 |
68 | MP0002925_abnormal_cardiovascular_devel | 0.48924032 |
69 | MP0000003_abnormal_adipose_tissue | 0.48539412 |
70 | MP0004043_abnormal_pH_regulation | 0.46369167 |
71 | MP0001299_abnormal_eye_distance/ | 0.44638724 |
72 | MP0008438_abnormal_cutaneous_collagen | 0.44069693 |
73 | MP0008004_abnormal_stomach_pH | 0.43277477 |
74 | MP0003984_embryonic_growth_retardation | 0.41521742 |
75 | MP0005187_abnormal_penis_morphology | 0.41517056 |
76 | MP0001784_abnormal_fluid_regulation | 0.41371140 |
77 | MP0002088_abnormal_embryonic_growth/wei | 0.40821908 |
78 | MP0009384_cardiac_valve_regurgitation | 0.38931957 |
79 | MP0002078_abnormal_glucose_homeostasis | 0.37846448 |
80 | MP0008961_abnormal_basal_metabolism | 0.37619300 |
81 | MP0005319_abnormal_enzyme/_coenzyme | 0.37371512 |
82 | MP0004147_increased_porphyrin_level | 0.37102788 |
83 | MP0001614_abnormal_blood_vessel | 0.36262055 |
84 | MP0002822_catalepsy | 0.35156740 |
85 | MP0003948_abnormal_gas_homeostasis | 0.34137305 |
86 | MP0009840_abnormal_foam_cell | 0.28573568 |
87 | MP0005595_abnormal_vascular_smooth | 0.28228727 |
88 | MP0003879_abnormal_hair_cell | 0.27426650 |
89 | MP0000762_abnormal_tongue_morphology | 0.25736889 |
90 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.25070053 |
91 | MP0005535_abnormal_body_temperature | 0.24913313 |
92 | MP0004924_abnormal_behavior | 0.24552610 |
93 | MP0005386_behavior/neurological_phenoty | 0.24552610 |
94 | MP0001984_abnormal_olfaction | 0.24468105 |
95 | MP0002638_abnormal_pupillary_reflex | 0.24229593 |
96 | MP0005377_hearing/vestibular/ear_phenot | 0.23900458 |
97 | MP0003878_abnormal_ear_physiology | 0.23900458 |
98 | MP0003941_abnormal_skin_development | 0.21207907 |
99 | MP0005380_embryogenesis_phenotype | 0.20846489 |
100 | MP0001672_abnormal_embryogenesis/_devel | 0.20846489 |
101 | MP0005388_respiratory_system_phenotype | 0.20285944 |
102 | MP0002133_abnormal_respiratory_system | 0.20285944 |
103 | MP0001727_abnormal_embryo_implantation | 0.19789638 |
104 | MP0005166_decreased_susceptibility_to | 0.19166654 |
105 | MP0004134_abnormal_chest_morphology | 0.18794577 |
106 | MP0009780_abnormal_chondrocyte_physiolo | 0.18739175 |
107 | MP0002896_abnormal_bone_mineralization | 0.18362716 |
108 | MP0005376_homeostasis/metabolism_phenot | 0.18225911 |
109 | MP0005167_abnormal_blood-brain_barrier | 0.18122501 |
110 | MP0000372_irregular_coat_pigmentation | 0.18046572 |
111 | MP0008569_lethality_at_weaning | 0.17074774 |
112 | MP0005334_abnormal_fat_pad | 0.17055298 |
113 | MP0008874_decreased_physiological_sensi | 0.16964136 |
114 | MP0010030_abnormal_orbit_morphology | 0.16879273 |
115 | MP0002066_abnormal_motor_capabilities/c | 0.16418852 |
116 | MP0000249_abnormal_blood_vessel | 0.16258430 |
117 | MP0005452_abnormal_adipose_tissue | 0.16049170 |
118 | MP0001943_abnormal_respiration | 0.16013819 |
119 | MP0002734_abnormal_mechanical_nocicepti | 0.15921306 |
120 | MP0002114_abnormal_axial_skeleton | 0.15770778 |
121 | MP0003122_maternal_imprinting | 0.15319237 |
122 | MP0001958_emphysema | 0.14747854 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 8.21208318 |
2 | Calf muscle hypertrophy (HP:0008981) | 6.60571941 |
3 | Ventricular tachycardia (HP:0004756) | 6.53915379 |
4 | Exercise-induced myalgia (HP:0003738) | 6.45100728 |
5 | Exercise-induced muscle cramps (HP:0003710) | 6.40556853 |
6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.14890580 |
7 | Muscle fiber splitting (HP:0003555) | 5.92273056 |
8 | Subaortic stenosis (HP:0001682) | 5.83192503 |
9 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.83192503 |
10 | Atrial fibrillation (HP:0005110) | 5.82595543 |
11 | Abnormality of the calf musculature (HP:0001430) | 5.58773847 |
12 | Primary atrial arrhythmia (HP:0001692) | 5.44870091 |
13 | Supraventricular tachycardia (HP:0004755) | 5.26642671 |
14 | Hyporeflexia of lower limbs (HP:0002600) | 5.18748739 |
15 | Supraventricular arrhythmia (HP:0005115) | 5.16490274 |
16 | * Lipoatrophy (HP:0100578) | 5.02013252 |
17 | Myoglobinuria (HP:0002913) | 4.73710546 |
18 | Right ventricular cardiomyopathy (HP:0011663) | 4.68109065 |
19 | Syncope (HP:0001279) | 4.67493831 |
20 | EMG: myopathic abnormalities (HP:0003458) | 4.62206286 |
21 | Prolonged QT interval (HP:0001657) | 4.40047665 |
22 | Asymmetric septal hypertrophy (HP:0001670) | 4.29973963 |
23 | Bundle branch block (HP:0011710) | 4.29652755 |
24 | Type 1 muscle fiber predominance (HP:0003803) | 4.23814630 |
25 | * Dilated cardiomyopathy (HP:0001644) | 4.17938431 |
26 | Ventricular arrhythmia (HP:0004308) | 4.13682408 |
27 | Palpitations (HP:0001962) | 4.12471274 |
28 | Ulnar deviation of the wrist (HP:0003049) | 4.04779476 |
29 | Muscle fiber inclusion bodies (HP:0100299) | 4.03439552 |
30 | Increased connective tissue (HP:0009025) | 3.99162525 |
31 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.94981248 |
32 | Ventricular fibrillation (HP:0001663) | 3.76006166 |
33 | Difficulty running (HP:0009046) | 3.68872095 |
34 | Rhabdomyolysis (HP:0003201) | 3.68131618 |
35 | Heart block (HP:0012722) | 3.63372878 |
36 | Calcaneovalgus deformity (HP:0001848) | 3.56912114 |
37 | Myotonia (HP:0002486) | 3.56055129 |
38 | Atrioventricular block (HP:0001678) | 3.52661226 |
39 | Abnormal atrioventricular conduction (HP:0005150) | 3.42852895 |
40 | Nemaline bodies (HP:0003798) | 3.33947724 |
41 | Abnormal EKG (HP:0003115) | 3.21609235 |
42 | Deformed tarsal bones (HP:0008119) | 3.14104036 |
43 | Absent phalangeal crease (HP:0006109) | 3.12742080 |
44 | Difficulty climbing stairs (HP:0003551) | 3.02668571 |
45 | Neck muscle weakness (HP:0000467) | 3.02263525 |
46 | Left ventricular hypertrophy (HP:0001712) | 2.91086622 |
47 | Malignant hyperthermia (HP:0002047) | 2.80388460 |
48 | Muscle stiffness (HP:0003552) | 2.73987289 |
49 | Distal lower limb muscle weakness (HP:0009053) | 2.67083307 |
50 | Increased variability in muscle fiber diameter (HP:0003557) | 2.66311282 |
51 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.62951722 |
52 | Areflexia of lower limbs (HP:0002522) | 2.59103909 |
53 | Abnormal finger flexion creases (HP:0006143) | 2.57342254 |
54 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.56885559 |
55 | Bulbar palsy (HP:0001283) | 2.54924050 |
56 | Fetal akinesia sequence (HP:0001989) | 2.54286531 |
57 | Hepatic necrosis (HP:0002605) | 2.53440965 |
58 | Acute necrotizing encephalopathy (HP:0006965) | 2.51136902 |
59 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.51014370 |
60 | * Palmoplantar keratoderma (HP:0000982) | 2.50776983 |
61 | Ragged-red muscle fibers (HP:0003200) | 2.49807511 |
62 | Rimmed vacuoles (HP:0003805) | 2.41760905 |
63 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.39426287 |
64 | EMG: neuropathic changes (HP:0003445) | 2.38501638 |
65 | Limb-girdle muscle atrophy (HP:0003797) | 2.33575772 |
66 | Distal arthrogryposis (HP:0005684) | 2.32933744 |
67 | Weak cry (HP:0001612) | 2.29784387 |
68 | Ketoacidosis (HP:0001993) | 2.24785503 |
69 | Generalized muscle weakness (HP:0003324) | 2.23799868 |
70 | Conjunctival hamartoma (HP:0100780) | 2.23274398 |
71 | Abnormality of the foot musculature (HP:0001436) | 2.23150775 |
72 | Hepatocellular necrosis (HP:0001404) | 2.20433140 |
73 | Fatigable weakness (HP:0003473) | 2.16136044 |
74 | Abnormality of the neuromuscular junction (HP:0003398) | 2.16136044 |
75 | Scapular winging (HP:0003691) | 2.11784112 |
76 | Testicular atrophy (HP:0000029) | 2.11367569 |
77 | Hypoglycemic coma (HP:0001325) | 2.10716462 |
78 | Distal lower limb amyotrophy (HP:0008944) | 2.10444316 |
79 | Acute encephalopathy (HP:0006846) | 2.09984875 |
80 | Sudden cardiac death (HP:0001645) | 2.07966440 |
81 | Congenital malformation of the right heart (HP:0011723) | 2.06805570 |
82 | Double outlet right ventricle (HP:0001719) | 2.06805570 |
83 | Gowers sign (HP:0003391) | 2.06510370 |
84 | Progressive macrocephaly (HP:0004481) | 2.05979196 |
85 | Mitochondrial inheritance (HP:0001427) | 2.05665046 |
86 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.04629516 |
87 | Increased muscle lipid content (HP:0009058) | 2.04293425 |
88 | Exercise intolerance (HP:0003546) | 2.02952827 |
89 | Round ear (HP:0100830) | 2.02677005 |
90 | Lower limb amyotrophy (HP:0007210) | 2.01399687 |
91 | Abnormality of the calcaneus (HP:0008364) | 2.00625600 |
92 | Muscular dystrophy (HP:0003560) | 1.99770414 |
93 | Popliteal pterygium (HP:0009756) | 1.98961251 |
94 | Foot dorsiflexor weakness (HP:0009027) | 1.97964076 |
95 | Hypoplastic ischia (HP:0003175) | 1.97731830 |
96 | Pheochromocytoma (HP:0002666) | 1.96932842 |
97 | Increased CSF lactate (HP:0002490) | 1.96648985 |
98 | Congestive heart failure (HP:0001635) | 1.96576414 |
99 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.95595751 |
100 | Myopathic facies (HP:0002058) | 1.93465213 |
101 | Waddling gait (HP:0002515) | 1.91293066 |
102 | Dicarboxylic aciduria (HP:0003215) | 1.90958147 |
103 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.90958147 |
104 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.89781964 |
105 | Spinal rigidity (HP:0003306) | 1.89639993 |
106 | Progressive muscle weakness (HP:0003323) | 1.88188193 |
107 | Facial diplegia (HP:0001349) | 1.88120334 |
108 | Cerebral edema (HP:0002181) | 1.87407859 |
109 | Dysmetric saccades (HP:0000641) | 1.85318789 |
110 | Hamartoma of the eye (HP:0010568) | 1.82728573 |
111 | Neoplasm of the adrenal gland (HP:0100631) | 1.82710437 |
112 | Increased intramyocellular lipid droplets (HP:0012240) | 1.82361048 |
113 | Steppage gait (HP:0003376) | 1.78482991 |
114 | Lactic acidosis (HP:0003128) | 1.77411454 |
115 | Frequent falls (HP:0002359) | 1.76898805 |
116 | Neuroendocrine neoplasm (HP:0100634) | 1.74953551 |
117 | Hip contracture (HP:0003273) | 1.73442883 |
118 | Proximal amyotrophy (HP:0007126) | 1.73401952 |
119 | Limited hip movement (HP:0008800) | 1.72603980 |
120 | Hyperalaninemia (HP:0003348) | 1.72071435 |
121 | Slender build (HP:0001533) | 1.71941298 |
122 | Type 2 muscle fiber atrophy (HP:0003554) | 1.69005649 |
123 | Hypoplastic heart (HP:0001961) | 1.61110575 |
124 | Hyperkalemia (HP:0002153) | 1.60947685 |
125 | Aplasia of the musculature (HP:0100854) | 1.59695823 |
126 | Metatarsus adductus (HP:0001840) | 1.59380823 |
127 | Muscle fiber atrophy (HP:0100295) | 1.53184572 |
128 | Limb-girdle muscle weakness (HP:0003325) | 1.53131213 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 6.15216483 |
2 | TTN | 5.61221920 |
3 | PHKG1 | 4.00826538 |
4 | PHKG2 | 4.00826538 |
5 | MYLK | 3.75480816 |
6 | LMTK2 | 3.35618333 |
7 | DMPK | 3.21326331 |
8 | PDK3 | 3.20665070 |
9 | PDK4 | 3.20665070 |
10 | PKN2 | 3.13949181 |
11 | TRIB3 | 2.62954339 |
12 | STK24 | 2.46755520 |
13 | NEK1 | 2.46533247 |
14 | MUSK | 2.35779546 |
15 | PIK3CA | 2.30835052 |
16 | TIE1 | 2.07742567 |
17 | BCKDK | 1.96207723 |
18 | PDK2 | 1.91575370 |
19 | PINK1 | 1.88981815 |
20 | ILK | 1.35400465 |
21 | MARK1 | 1.35127197 |
22 | ZAK | 1.34707810 |
23 | CDC42BPA | 1.22843650 |
24 | PAK3 | 1.22239723 |
25 | PRKD1 | 1.19932495 |
26 | MAP3K7 | 1.18192469 |
27 | GRK7 | 1.16971774 |
28 | CAMK2D | 1.15510367 |
29 | MAPK12 | 1.11381992 |
30 | STK38L | 1.08330151 |
31 | ROCK1 | 1.07579697 |
32 | EEF2K | 1.02993598 |
33 | MAP2K3 | 0.95479801 |
34 | CCNB1 | 0.92566241 |
35 | TRPM7 | 0.90644350 |
36 | MAP3K5 | 0.90494904 |
37 | DAPK3 | 0.87088628 |
38 | MAPKAPK3 | 0.85694833 |
39 | PIK3CG | 0.85299513 |
40 | PRKAA1 | 0.85126178 |
41 | STK4 | 0.84433140 |
42 | RIPK1 | 0.84396761 |
43 | FLT3 | 0.83586909 |
44 | WNK4 | 0.82955599 |
45 | PRKAA2 | 0.78358008 |
46 | NME1 | 0.77490480 |
47 | INSRR | 0.77056511 |
48 | MOS | 0.74309380 |
49 | MAP3K3 | 0.73311709 |
50 | STK38 | 0.71141075 |
51 | PKN1 | 0.69733645 |
52 | MAPK4 | 0.69342200 |
53 | CAMK4 | 0.64702074 |
54 | PTK2B | 0.64614615 |
55 | KSR2 | 0.61034515 |
56 | PDGFRA | 0.60199339 |
57 | CAMK2A | 0.58673592 |
58 | CAMK2B | 0.58198966 |
59 | ROCK2 | 0.57268426 |
60 | CAMK1 | 0.56356555 |
61 | ERBB3 | 0.55130277 |
62 | WNK1 | 0.54387015 |
63 | EPHA3 | 0.51944568 |
64 | MAP2K1 | 0.51799382 |
65 | MAP3K6 | 0.50055135 |
66 | PRKACB | 0.49844620 |
67 | KDR | 0.49721995 |
68 | DYRK1B | 0.48371097 |
69 | RPS6KC1 | 0.47682784 |
70 | RPS6KL1 | 0.47682784 |
71 | TGFBR2 | 0.47546267 |
72 | AKT2 | 0.44962670 |
73 | UHMK1 | 0.43456131 |
74 | PRKD3 | 0.40560718 |
75 | PRKACA | 0.39430032 |
76 | RPS6KA6 | 0.38925806 |
77 | PRKCE | 0.38791584 |
78 | ICK | 0.37965475 |
79 | EPHB1 | 0.37941380 |
80 | CAMK2G | 0.36776836 |
81 | PDPK1 | 0.34515745 |
82 | PRKACG | 0.34178543 |
83 | MAPK10 | 0.31692666 |
84 | MARK2 | 0.29482038 |
85 | PDK1 | 0.29198090 |
86 | NEK9 | 0.29044814 |
87 | STK39 | 0.28477052 |
88 | PRKCH | 0.27817535 |
89 | MAP3K13 | 0.27333891 |
90 | PTK6 | 0.26460448 |
91 | ARAF | 0.25515413 |
92 | RAF1 | 0.25099535 |
93 | SIK1 | 0.24956778 |
94 | LATS2 | 0.24469563 |
95 | SGK3 | 0.23353639 |
96 | PRKG1 | 0.22999043 |
97 | TAOK1 | 0.22707098 |
98 | MAP2K4 | 0.22684828 |
99 | TBK1 | 0.21044589 |
100 | RPS6KA1 | 0.19740604 |
101 | MAP3K10 | 0.19569429 |
102 | SGK1 | 0.19479348 |
103 | LATS1 | 0.19240745 |
104 | DDR2 | 0.19049424 |
105 | SGK223 | 0.18989359 |
106 | SGK494 | 0.18989359 |
107 | EPHB2 | 0.18637477 |
108 | FER | 0.17832686 |
109 | MAPK11 | 0.17270644 |
110 | STK11 | 0.17254788 |
111 | PRKG2 | 0.17199218 |
112 | RPS6KA3 | 0.17009149 |
113 | LIMK1 | 0.16796938 |
114 | MAPK7 | 0.16115820 |
115 | RPS6KB2 | 0.15839890 |
116 | MTOR | 0.15420573 |
117 | RET | 0.14314516 |
118 | MAP2K6 | 0.13646681 |
119 | PAK6 | 0.12875703 |
120 | RPS6KA2 | 0.10811120 |
121 | JAK1 | 0.08041729 |
122 | MAP3K1 | 0.07231924 |
123 | MARK3 | 0.07192487 |
124 | SGK2 | 0.06780304 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.89149797 |
2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.75397226 |
3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.25399662 |
4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.16805634 |
5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.12733513 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.13667782 |
7 | Parkinsons disease_Homo sapiens_hsa05012 | 3.10937441 |
8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.93267252 |
9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.86615410 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53036318 |
11 | * Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.47825021 |
12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.41569367 |
13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.28457500 |
14 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.10053448 |
15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.00855317 |
16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.91210114 |
17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89222113 |
18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.85618298 |
19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.79142281 |
20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.62988766 |
21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.35526383 |
22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.31665483 |
23 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.20141519 |
24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18459012 |
25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.17313581 |
26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.14845520 |
27 | Insulin resistance_Homo sapiens_hsa04931 | 1.11011468 |
28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09270595 |
29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02810572 |
30 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.99703540 |
31 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98375436 |
32 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95602800 |
33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.95473431 |
34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.88356961 |
35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.86184341 |
36 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82860428 |
37 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.82092871 |
38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79104616 |
39 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74515159 |
40 | * Focal adhesion_Homo sapiens_hsa04510 | 0.73073619 |
41 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71480895 |
42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69925690 |
43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69226674 |
44 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68796296 |
45 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68458152 |
46 | Lysine degradation_Homo sapiens_hsa00310 | 0.67986623 |
47 | * Tight junction_Homo sapiens_hsa04530 | 0.66026461 |
48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62479468 |
49 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60314190 |
50 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.59078448 |
51 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.58663208 |
52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58297547 |
53 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57214486 |
54 | Renin secretion_Homo sapiens_hsa04924 | 0.56963027 |
55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55733190 |
56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55411975 |
57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55241161 |
58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.51400997 |
59 | Insulin secretion_Homo sapiens_hsa04911 | 0.50654776 |
60 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50269412 |
61 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.48082453 |
62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47215801 |
63 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46924982 |
64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.46278722 |
65 | Circadian entrainment_Homo sapiens_hsa04713 | 0.45755871 |
66 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44220326 |
67 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41564362 |
68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41339702 |
69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37558661 |
70 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.37429870 |
71 | Olfactory transduction_Homo sapiens_hsa04740 | 0.28101156 |
72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27357730 |
73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27049339 |
74 | GABAergic synapse_Homo sapiens_hsa04727 | 0.25926484 |
75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.25273934 |
76 | Peroxisome_Homo sapiens_hsa04146 | 0.24242773 |
77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24223741 |
78 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23641612 |
79 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.21679088 |
80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21574055 |
81 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.20822022 |
82 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.20021383 |
83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19296374 |
84 | Platelet activation_Homo sapiens_hsa04611 | 0.18813539 |
85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18493923 |
86 | Gap junction_Homo sapiens_hsa04540 | 0.17542087 |
87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.17202076 |
88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.17176894 |
89 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.17012862 |
90 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.16374685 |
91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.15755933 |
92 | Glioma_Homo sapiens_hsa05214 | 0.15328356 |
93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.15252780 |
94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.15226211 |
95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.14635235 |
96 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.14179281 |
97 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.13950326 |
98 | * Amoebiasis_Homo sapiens_hsa05146 | 0.13418592 |
99 | * Adherens junction_Homo sapiens_hsa04520 | 0.13064535 |
100 | Taste transduction_Homo sapiens_hsa04742 | 0.12111165 |
101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.12094465 |
102 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.11233546 |
103 | Salivary secretion_Homo sapiens_hsa04970 | 0.10890059 |
104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.09240199 |
105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.08962342 |
106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.08122163 |
107 | Long-term potentiation_Homo sapiens_hsa04720 | 0.07496935 |
108 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.07327632 |
109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.06498965 |
110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.04951260 |
111 | Melanogenesis_Homo sapiens_hsa04916 | 0.04506201 |
112 | Morphine addiction_Homo sapiens_hsa05032 | 0.04282044 |
113 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.03303453 |
114 | Bile secretion_Homo sapiens_hsa04976 | 0.02510068 |